These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 7625799

  • 1. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H, Akagi H, Masaru Y, Otani T, Hyodo A, Hiramatsu K.
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [Abstract] [Full Text] [Related]

  • 2. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S, Hanaki H, Unemi N.
    Chemotherapy; 1996 May; 42(4):253-8. PubMed ID: 8804792
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T, Otsuki M, Hatano K, Nishihara Y.
    Chemotherapy; 1994 May; 40(3):167-82. PubMed ID: 8205935
    [Abstract] [Full Text] [Related]

  • 4. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Kamimura T, Tawara S, Matsumoto Y, Matsumoto F, Kuwahara S.
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [Abstract] [Full Text] [Related]

  • 5. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T, Tsushima M, Ishii T, Atsumi K, Tamura A.
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
    Hata K, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1894-901. PubMed ID: 1416879
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [Abstract] [Full Text] [Related]

  • 8. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
    Eng RH, Cherubin CE, Smith SM, Buccini F, Harris R.
    J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis.
    Nomura S, Hanaki H, Furukawa T, Unemi N.
    Chemotherapy; 1996 Mar; 42(6):432-8. PubMed ID: 8957577
    [Abstract] [Full Text] [Related]

  • 10. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME.
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [Abstract] [Full Text] [Related]

  • 11. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG, Lam A, Schweizer F, Thomson K, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Noreddin AM, Karlowsky JA.
    Am J Clin Dermatol; 2008 Jun; 9(4):245-54. PubMed ID: 18572975
    [Abstract] [Full Text] [Related]

  • 12. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N.
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM, Aranza MK, Shah D, Sahm DF.
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
    Fujimura T, Yamano Y, Yoshida I, Shimada J, Kuwahara S.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
    [Abstract] [Full Text] [Related]

  • 15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Fujime M, Fujita K, Shigeta S, Watanabe J, Igari J, Ogiwara M, Ishibashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Matsumoto T, Kashitani F, Murai M, Ooe H, Nishikawa M, Watanabe K, Kobayashi Y, Uchida H, Oka T, Mochida C.
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [Abstract] [Full Text] [Related]

  • 16. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Higashi Y, Kamimura T, Matsumoto Y, Tawara S, Matsumoto F.
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [Abstract] [Full Text] [Related]

  • 17. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G, Isert D, Klesel N, Limbert M, Markus A, Schrinner E.
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
    [Abstract] [Full Text] [Related]

  • 18. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K, Inoue E, Mitsuhashi S.
    Chemotherapy; 1995 Apr; 41(4):257-66. PubMed ID: 7555206
    [Abstract] [Full Text] [Related]

  • 19. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.
    Tsuji M, Takema M, Miwa H, Shimada J, Kuwahara S.
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2507-12. PubMed ID: 12878512
    [Abstract] [Full Text] [Related]

  • 20. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.